Biochemical bone turnover markers in patients with ankylosing

Clinical Rheumatology

Volumn 19, Issue 2, 2000, Pages 92-98

  Yilmaz, Necat ^a   Ozaslan J ^b  

^a GAZIANTEP UNIVERSITY   (Turkey)

^b NONE

Author keywords

Ankylosing spondylitis; Deoxypyridinoline; Erythrocyte sedimentation rate; Pyridinoline

Indexed keywords

ALKALINE PHOSPHATASE; BIOCHEMICAL MARKER; C REACTIVE PROTEIN; DEOXYPYRIDINOLINE; MINERAL; OSTEOCALCIN; PYRIDINOLINE; TESTOSTERONE;

ADULT; AGED; ALKALINE PHOSPHATASE BLOOD LEVEL; ANKYLOSING SPONDYLITIS; ARTICLE; BONE METABOLISM; BONE TURNOVER; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ACTIVITY; DISEASE DURATION; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; HUMAN; MALE; MINERAL BLOOD LEVEL; OSTEOLYSIS; PRIORITY JOURNAL; TESTOSTERONE BLOOD LEVEL; URINARY EXCRETION;

ADULT; AGED; ALKALINE PHOSPHATASE; AMINO ACIDS; BIOLOGICAL MARKERS; BLOOD SEDIMENTATION; BONE AND BONES; FEMALE; HUMANS; MALE; MIDDLE AGED; OSTEOBLASTS; OSTEOCALCIN; SPONDYLITIS, ANKYLOSING;

EID: 0034055707     PISSN: 07703198     EISSN: None     Source Type: Journal    
DOI: 10.1007/s100670050024     Document Type: Article

References (42)

1. Gran JT, Skomsvoll JF. The outcome of ankylosing spondylitis: a study of 100 patients. Br J Rheumatol 1997;36:766-71.
2. Dana JMB, Tsuchiya N, Yamaguchi A, Kenny TP, Robbins DL. Immunologic mechanism in common rheumatologic diseases. Clin Orthop Rel Res. 1996;326:43-54.
3. Casals-Sanchez JL, Gonzalez-Calvin J, Garcia-Sanchez A, Abellan-Perez M, Salvatierra-Rios D. Clinical activity and serum immunoglobulin concentrations in patients with ankylosing spondylitis. An Med Interna. 1992;9:214-6.
4. Toussirot E, Wendling D. Osteoporosis in ankylosing spondylitis. Press Med 1996;25:70-4.
5. Tapia-Serrano R, Jimenez-Balderas FJ, Murrieta S, Bravo-Gatica C, Guerra R, Mintz G. Testicular function in active ankylosing spondylitis. Therapeutic response to human chorionic gonadotropin. J Rheumatol 1991;18:841-8.
6. Bronson WD, Walker SE, Hillman LS, Keisler D, Hoyt T, Allen SH. Bone mineral density and biochemical markers of bone metabolism in ankylosing spondylitis. J Rheumatol 1998;25:929-35.
7. Murray GC, Persellin RH. Cervical fracture complicating ankylosing spondylitis: a report of eight cases and review of the literature. Am J Med 1981;70:1033-41.
8. Handling JR, McCall IW, Park WM, Jones BF. Fracture of the cervical spine in ankylosing spondylitis. Br J Radiol 1985;58:3-7.
9. Hunter T, Dubo H. Spinal fractures complicating ankylosing spondylitis. Ann Intern Med 1978;88:546-9.
10. Yilmaz N, Bayram M, Erbaǧct AB, Kilinçer MS. Diagnostic value of biochemical markers of bone turnover and postmenopausal osteoporosis. Clin Chem Lab Med 1999;37:137-43.
11. Westerhuis LWJJM, Delaere KPJ. Diagnostic value of some biochemical bone markers for the detection bone metastases in prostate cancer. Eur J Clin Chem Clin Biochem 1997;35:89-94.
12. Rosalki SB. Biochemical markers of bone turnover. Int J Clin Prac 1998;52:255-6.
13. Suzuki M, Takahashi S, Miyamoto S, Hoshino H, Kushida K, Miura M, Inoue T. The effects of menopausal status and diseases activity on biochemical markers of bone metabolism in female patients with rheumatoid arthritis. Br J Rheumatol 1998;37:653-8.
14. Ohishi T, Takahashi M, Kawana K, Aoshima H, Hoshino H, Horiuchi K, et al. Age-related changes of urinary pyridinoline and deoxypyridinoline in Japanese subjects. Clin Invest Med 1993;16:319-25.
15. Sinigaglia L, Varenna M, Binelli L, Bartucci F, Arrigoni M, Ferrara R, Abbiati G. Urinary and synovial pyridinium cross-link concentrations in patients with rheumatoid arthritis and osteoarthritis. Ann Rheum Dis 1995;54:144-7.
16. Schneider U, Breusch SJ, Termath S, Thomsen M, Brocai DRC, Niethard FU, Kasperk C. Increased urinary crosslink levels in aseptic loosening of total hip arthroplasty. J Arthro 1998;13:687-92.
17. Shaarawy M, El-Dawakhly AS, Mosaad M, El-Sadek MM. Biomarkers of bone turnover and bone mineral density in hyperprolactinemic amenorrheic women. Clin Chem Lab Med 1999;37:433-8.
18. Gough A, Sambrook P, Devlin J, Huissoon A, Njeh C, Robbins S, et al. Osteoclastic activation is the principal mechanism leading to secondary in rheumatoid arthritis. J Rheumatol 1998;25:1282-9.
19. Garnero P, Delmos PD. Assessment of the serum levels of bone alkaline phosphatase with a new immunoradiometric assay in patients with metabolic bone diseases. J Clin Endocrinol Metab 1993;77:1046-53.
20. Moll JMH, Wright V. New York clinical criteria for ankylosing spondylitis. Ann Rheum Dis 1973;32:354-63.
21. Garrett S, Jenkinson T, Kennedy LG, Whitelock H, Gaisford P, Calin A. A new approach to defining disease status in ankylosing spondylitis: the Bath Ankylosing Spondylitis Diseases Activity Index. J Rheumatol 1994;21:2286-91.
22. Gomez B jr, Ardakani S, Evans BJ, Merrell LD, Jenkins DK, Kung VT. Monoclonal antibody assay for the free urinary pyridium cross-links. Clin Chem 1996;42:1168-75.
23. Aloia JF, Mikhail M, Pagan CD, Arunacha-lam A, Yeh JK, Flaster E. Biochemical and hormonal variables in black and white women matched for age and weight. J Lab Clin Med 1998;132:383-9.
24. Giltay EJ, Popp-Snijders C, van Schaardenburg D, Dekker-Saeys BJ, Gooren LJG, Dijkmans BAC. Serum testosterone levels are not elevated in patients with ankylosing spondylitis. J Rheumatol 1998;25:2389-94.
25. Takahashi M, Suzuki M, Naitou K, Miyamoto S, Kushida K. Comparison of free and peptide-bound pyridinoline cross-links excretion in rheumatoid arthritis and osteoarthritis. Rheumatology 1999;38:133-8.
26. Petersson IF, Boegard T, Dahlstrom J, Svensson B, Heinegard D, Saxne T. Bone scan and serum markers of bone and cartilage in patients with knee pain and osteoarthritis. Osteoarthritis and Cartilage 1998;6:33-9.
27. Toussirot E, Ricard-Blum S, Dumoulin G, Cedoz JP, Wendling D. Relationship between urinary pyridinium cross-links, disease activity and disease subsets of ankylosing spondylitis. Rheumatology 1999;38:21-7.
28. Robins SP, Duncan A, Wilson N, Evans BJ. Standardisation of pyridinium crosslinks, pyridinoline and deoxypridinoline, for use as biochemical markers of collagen degradation. Clin Chem 1996;42:1621-6.
29. Kojima N, Sakata S, Nagai K, Takuno H, Ogawa T, Matsui I, et al. Serum concentration of osteocalcin in patients with hyperthyroidism. J Endocrinol Invest 1992;15:491-6.
30. Deftos LJ, Wolfer RL, Hill CS. Bone alkaline phosphatase in Paget's diseases. Horm Metab Res 1991;23:559-61.
31. Acebes JC, Armas J, Aznar E, Armas C, Herrero-Beaumont G. Bone metabolism in patients with ankylosing spondylitis. Br J Rheumatol 1997;1[ABS suppl]:127.
32. Donelly S, Doyle DV, Denton A, Rolfe I, McCloskey EV, Spector TD. Bone mineral density and vertebral compression fracture rates in ankylosing spondylitis. Ann Rheum Dis 1994;53:117-21.
33. Sivri A, Kilinc S, Gökce Kutsal Y, Ariyurek M. Bone mineral density in ankylosing spondylitis. Clin Rheumatol 1996;15:51-4.
34. Lanyi E, Gömör B, Ratko I. Determination of diminished mineral density in ankylosing spondylitis. Orv Hetil 1997;138:2227-9.
35. Marhoffer W, Stracke H, Masoud I, Scheja M, Graef V, Bolten W, Federlin K. Evidence of impaired cartilage/bone turnover in patients with active ankylosing spondylitis. Ann Rheum Dis 1995;57:556-9.
36. Macdonald AG, Birkinshaw G, Durham B, Bucknall RC, Fraser WD. Biochemical markers of bone turnover in seronegative spondylarthropathy: relationship to disease activity. Br J Rheumatol 1997;35:50-3.
37. Beck-Jensen JE, Kollerup G, Sorensen HA, Pors-Nielsen S, Sorensen OH. A single measurement of biochemical markers of bone turnover has limited utility in the individual person. Scand J Clin Invest 1997;57:351-9.
38. Withold W. Monitoring of bone turnover biological, preanalytical and technical criteria in the assessment of biochemical markers. Eur J Clin Chem Clin Biochem 1996;34:785-99.
39. Ju HS, Leung S, Brown B, Stringer MA, Leigh S, Scherrer C, et al. Comparison of analytical performance and biological variability of three bone resorption assays. Clin Chem 1997;43:1570-6.
40. Franck H, Keck E. Serum osteocalcin and vitamin D metabolites in patients with ankylosing spondylitis. Ann Rheum Dis 1993;52:343-6.
41. Jajic Z, Jajic I, Dubravica M. Rheumatoid arthritis and ankylosing spondylitis. Reumatizam 1995;42:15-7.
42. Dequeker J, Maenaut K, Verwilgen J, Westhovens R. Osteoporosis in rheumatoid arthritis. Clin Exp Rheumatol 1995;13 [suppl 12]:S21-6.